MDS Pharma Services Launches New Brand Campaign to Support Client Service Strategy
12 Novembre 2007 - 2:00PM
PR Newswire (US)
KING OF PRUSSIA, PA, Nov. 12 /PRNewswire-FirstCall/ -- MDS Pharma
Services, a leading provider of innovative drug discovery and
development solutions, has launched a new brand promise - "to
deliver high-quality services on-time" - as part of their strategic
plan to become the industry leader in quality, compliance and
client service. This new brand campaign has been developed in
response to market research with hundreds of clients around the
world. The research revealed that high quality, on-time delivery is
a top priority with clients striving to move new drugs to market
quickly and efficiently. "We recognize the importance of high
quality, on-time delivery for clients in every phase of the drug
discovery and development process," said MDS Pharma Services
President David Spaight. "At MDS Pharma Services, our employees are
committed to this brand promise as part of our global strategy to
support our clients' success." MDS Pharma Services unveiled its new
brand campaign at the annual meeting of the American Association of
Pharmaceutical Scientists (AAPS) which opened yesterday in San
Diego. This new branding has been captured visually with a high
speed train moving to its destination on-time. This brand image
will be promoted online, in print and at more than two dozen
industry events in the coming year. The brand promise is also
reflected in the contract research organization's operational
priorities. These priorities emphasize providing high quality,
on-time services by investing in new customer facing information
technology systems and by using LeanSigma and other process
improvement initiatives to expedite the drug discovery and
development process. MDS Pharma Services has almost 100 LeanSigma
projects completed or underway to reduce the time for clients to
reach milestones such as the start-up of studies, biomarker
development methods and report delivery. About MDS Pharma Services
MDS Pharma Services is committed to its brand promise of delivering
high-quality services on-time to clients. The business offers a
full spectrum of resources to meet the drug discovery and
development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around
the world, we apply advanced scientific and technological expertise
throughout the drug discovery and development process - from lead
optimization, pre-IND research, early clinical research
(bioequivalence, phases I-IIa) and bioanalysis through to global
clinical development (phases IIb-IV), central lab and centralized
cardiac services. For more information, visit our website at
http://www.mdsps.com/. MDS Pharma Services is a business unit of
MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company that
provides market-leading products and services that our customers
need for the development of drugs and diagnosis and treatment of
disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than
6,200 highly skilled people in 28 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Pharma Services CONTACT: For Investors: Sharon
Mathers, (416) 675-6777 ext. 34721, ; For Media: Charlene McGrady,
(610) 239-7900 ext. 231,
Copyright